Rémi Delansorne
Geen lopende functies
Profiel
Rémi Delansorne served as the Chief Executive Officer & Director at Hybrigenics SA from 2007 to 2017.
Prior to that, he worked at Hybrigenics SA from 2004 to 2020.
He also worked as the Head-Diabetes Research at Merck Serono Ltd.
Dr. Delansorne holds a doctorate degree from Université Pierre et Marie Curie and a doctorate degree from École Nationale Vétérinaire d'Alfort.
Eerdere bekende functies van Rémi Delansorne
| Bedrijven | Functie | Einde |
|---|---|---|
| ATON | Chief Executive Officer | 12-03-2020 |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Rémi Delansorne
| École Nationale Vétérinaire d'Alfort | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ATON | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
